AHG Company Profile and Key Details

Akso Health Group has 854.04 million shares outstanding. This equals 38.32 thousand shares. The short ratio is 2.61 days. Institutional investors hold 151.0% of the float. Insiders own 0.0%. HIGBY LAWRENCE M holds 154.77 thousand shares, TOUPS JOHN M has 24.17 thousand shares and RYLES GERALD F has 6.30 thousand shares.

Akso Health Group generated EPS of -$0.47 over the past year. Five-year average earnings growth is 35.9%.

AHG has shown mixed momentum, losing -1.3% over the past week and -7.32% over the past quarter, though year-to-date performance is down -7.32%. Short-term trend indicators are bullishly aligned (SMA20 -1.47%, SMA50 -1.67%, SMA200 -10.43%). The stock’s 14-day RSI is 48.9 (neutral), while the ATR of 0.14 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -33.33% below its high and over 68.47% above its low. Average 10-day trading volume of 6.57 thousand shares is below the 3-month average of 38.16 thousand, indicating normal recent market interest.

Akso Health Group last paid a dividend of 1.2 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.88. This means the shares are trading below this model’s fair value.

Akso Health Group (NASDAQ:AHG) closed at $1.57 USD, losing -$0.02 (-1.26%) from the previous close of $1.59. The stock is currently mid-range between its 52-week high and low $1.10 and $2.50. With a market capitalization of about $148.73 million, Akso Health Group is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.00). Key stats such as the average daily volume over the past year has been around 39.68 thousand shares, volume is running light vs its 52-week average. Headquartered in Qingdao, SD, Akso Health Group operates in the Technology sector and the Software - Services industry. Led by CEO Yilin Wang, the company employs approximately 27 people and listed since November 03, 2017. Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China.

Akso Health Group trades at a P/E ratio of -6.77, slightly below the S&P 500 average, with a price-to-sales ratio of 17.58 and a price-to-book ratio of 1.08 suggesting the stock is closer to book value. The P/FCF stands at -1.55, also above market averages.

Our AI price prediction model suggests that Akso Health Group stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.64%, with price expected at $1.58 by August 14, 2026, within a range of $1.51 to $1.65 3-Month Outlook: Projected fall of -49.04%, reaching $0.80 by October 29, 2026, with a range of $0.67 to $0.88. 1-Year Outlook: Projected gain of 907.64%, with price at $15.82 by July 30, 2027, within a range of $14.34 to $19.67.

Akso Health Group (NASDAQ:AHG) shares are flat -7.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Akso Health Group trading at a premium to the broader market with a P/E of -6.77. Our AI forecast model points to short-term strength (0.64% over two weeks), a medium-term fall (-49.04% over three months), and a longer-term gain (907.64% over one year), with expected trading ranges indicating moderate volatility.